Next Article in Journal
Factors Affecting Mortality Following Hip Fracture Surgery: Insights from a Long-Term Study at a Level I Trauma Center—Does Timing Matter?
Previous Article in Journal
The Rising Global Cesarean Section Rates and Their Impact on Maternal and Child Health: A Scoping Review
Previous Article in Special Issue
Advancing Heart Failure Care: Breakthroughs and Emerging Strategies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 14
Issue 22
10.3390/jcm14228103
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Treatment of Severe Tricuspid Regurgitation with the TricValve System Implantation—Preliminary Results of a Prospective Registry

by
Adam Rdzanek
1,*,†,
Maciej Dąbrowski
2,†,
Ewa Pędzich
1,
Mariusz Tomaniak
1,
Piotr N. Rudziński
3,
Agnieszka Kapłon-Cieślicka
1,
Adam Piasecki
1,
Janusz Kochman
1,
Adam Witkowski
2 and
Piotr Scisło
1
1
1st Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland
2
Department of Interventional Cardiology and Angiology, National Institute of Cardiology, 04-628 Warsaw, Poland
3
Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 04-628 Warsaw, Poland
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
J. Clin. Med. 2025, 14(22), 8103; https://doi.org/10.3390/jcm14228103 (registering DOI)
Submission received: 2 October 2025 / Revised: 12 November 2025 / Accepted: 14 November 2025 / Published: 15 November 2025
(This article belongs to the Special Issue Acute and Chronic Heart Failure: Clinical Updates and Perspectives)
Versions Notes

Abstract

Background: Tricuspid regurgitation (TR) is a common valvular heart disease that often causes disabling symptoms. Caval valve implantation with the TricValve system is one of the transcatheter treatment options proposed for TR symptom reduction. With this prospective registry, we aim to summarize our early experience with TricValve system implantation. Methods: Registry participants, selected out of patients who were referred for TR treatment but who were not eligible for the transcatheter tricuspid edge-to-edge valve repair (T-TEER), were qualified for the caval valve implantation following a HeartTeam discussion. Results: Four patients (four women; median age 71 years; 67.5–77 years) in whom a one-year follow-up was completed were included in the study. The patients were highly symptomatic in the NYHA class III despite intensive diuretic treatment; all of them were considered a high-mortality risk during conventional cardiac surgery. The TricValve system was successfully implanted in all patients. At 6-month follow-up, we observed a reduction in symptoms in three out of four patients. Up to 12 months, only one patient survived, with a reduction in symptoms of NYHA class II; two patients died because of heart failure; one died due to a progression in neoplastic disease. Conclusions: In highly symptomatic TR patients who were not eligible for the T-TEER and who had a prohibitive risk of cardiac surgery, TricValve implantation led to a reduction in symptoms in a 6-month perspective. Long-term survival was limited mainly by heart failure progression and severe concomitant disorders. Further studies are needed to fully elucidate the role of caval valve implantation in the treatment of TR patients.
Keywords: caval valve implantation; tricuspid regurgitation; TricValve system caval valve implantation; tricuspid regurgitation; TricValve system

Share and Cite

MDPI and ACS Style

Rdzanek, A.; Dąbrowski, M.; Pędzich, E.; Tomaniak, M.; Rudziński, P.N.; Kapłon-Cieślicka, A.; Piasecki, A.; Kochman, J.; Witkowski, A.; Scisło, P. Treatment of Severe Tricuspid Regurgitation with the TricValve System Implantation—Preliminary Results of a Prospective Registry. J. Clin. Med. 2025, 14, 8103. https://doi.org/10.3390/jcm14228103

AMA Style

Rdzanek A, Dąbrowski M, Pędzich E, Tomaniak M, Rudziński PN, Kapłon-Cieślicka A, Piasecki A, Kochman J, Witkowski A, Scisło P. Treatment of Severe Tricuspid Regurgitation with the TricValve System Implantation—Preliminary Results of a Prospective Registry. Journal of Clinical Medicine. 2025; 14(22):8103. https://doi.org/10.3390/jcm14228103

Chicago/Turabian Style

Rdzanek, Adam, Maciej Dąbrowski, Ewa Pędzich, Mariusz Tomaniak, Piotr N. Rudziński, Agnieszka Kapłon-Cieślicka, Adam Piasecki, Janusz Kochman, Adam Witkowski, and Piotr Scisło. 2025. "Treatment of Severe Tricuspid Regurgitation with the TricValve System Implantation—Preliminary Results of a Prospective Registry" Journal of Clinical Medicine 14, no. 22: 8103. https://doi.org/10.3390/jcm14228103

APA Style

Rdzanek, A., Dąbrowski, M., Pędzich, E., Tomaniak, M., Rudziński, P. N., Kapłon-Cieślicka, A., Piasecki, A., Kochman, J., Witkowski, A., & Scisło, P. (2025). Treatment of Severe Tricuspid Regurgitation with the TricValve System Implantation—Preliminary Results of a Prospective Registry. Journal of Clinical Medicine, 14(22), 8103. https://doi.org/10.3390/jcm14228103

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop